Response of 1,5-anhydroglucitol to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial

BACKGROUND: Low 1,5-anhydroglucitol (1,5-AG) is a marker of glycosuric hyperglycemia. We evaluated 1,5-AG with clinical outcomes and assessed the effects of glucose- and blood pressure-lowering interventions on change in 1,5-AG in type 2 diabetes. METHODS: We measured 1,5-AG in 6,826 stored samples...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes Obes Metab
Auteurs principaux: Selvin, Elizabeth, Wang, Dan, McEvoy, John William, Juraschek, Stephen P., Lazo, Mariana, Hamet, Pavel, Cooper, Mark, Marre, Michel, Williams, Bryan, Harrap, Stephen, Chalmers, John, Woodward, Mark
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6620118/
https://ncbi.nlm.nih.gov/pubmed/31050156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13755
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires